BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park JS, Seo JH, Youn HS. Gut microbiota and clinical disease: obesity and nonalcoholic Fatty liver disease. Pediatr Gastroenterol Hepatol Nutr. 2013;16:22-27. [PMID: 24010102 DOI: 10.5223/pghn.2013.16.1.22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Tsuei J, Chau T, Mills D, Wan YJ. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) 2014;239:1489-504. [PMID: 24951470 DOI: 10.1177/1535370214538743] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 6.6] [Reference Citation Analysis]
2 Fernández-Navarro T, Salazar N, Gutiérrez-Díaz I, de Los Reyes-Gavilán CG, Gueimonde M, González S. Different Intestinal Microbial Profile in Over-Weight and Obese Subjects Consuming a Diet with Low Content of Fiber and Antioxidants. Nutrients 2017;9:E551. [PMID: 28555008 DOI: 10.3390/nu9060551] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
3 Ball J, McAnulty G. Ignoring our evolution: the 'pandemic' of over-nutrition and under-activity. Not simply a metabolic syndrome? Anaesthesia 2014;69:203-7. [PMID: 24548351 DOI: 10.1111/anae.12599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Elvira-Torales LI, Periago MJ, González-Barrio R, Hidalgo N, Navarro-González I, Gómez-Gallego C, Masuero D, Soini E, Vrhovsek U, García-Alonso FJ. Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). Food Funct 2019;10:2148-60. [PMID: 30938723 DOI: 10.1039/c8fo01630e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
5 Fernández-navarro T, Díaz I, Gutiérrez-díaz I, Rodríguez-carrio J, Suárez A, de los Reyes-gavilán CG, Gueimonde M, Salazar N, González S. Exploring the interactions between serum free fatty acids and fecal microbiota in obesity through a machine learning algorithm. Food Research International 2019;121:533-41. [DOI: 10.1016/j.foodres.2018.12.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
6 Riordan JD, Nadeau JH. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mamm Genome 2014;25:473-86. [PMID: 24802098 DOI: 10.1007/s00335-014-9521-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
7 Alisi A, Bedogni G, Baviera G, Giorgio V, Porro E, Paris C, Giammaria P, Reali L, Anania F, Nobili V. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2014;39:1276-1285. [PMID: 24738701 DOI: 10.1111/apt.12758] [Cited by in Crossref: 232] [Cited by in F6Publishing: 189] [Article Influence: 33.1] [Reference Citation Analysis]
8 Araújo FO, Moreira MEC, Lima CF, Toledo RCL, de Sousa AR, Veloso MP, de Freitas PG, Dos Santos MH, de Souza ECG, Mantovani HC, Martino HSD. Bacupari (Garcinia brasiliensis) extract modulates intestinal microbiota and reduces oxidative stress and inflammation in obese rats. Food Res Int 2019;122:199-208. [PMID: 31229073 DOI: 10.1016/j.foodres.2019.04.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
9 Liu Q, Liu S, Chen L, Zhao Z, Du S, Dong Q, Xin Y, Xuan S. Role and effective therapeutic target of gut microbiota in NAFLD/NASH. Exp Ther Med 2019;18:1935-44. [PMID: 31410156 DOI: 10.3892/etm.2019.7781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Mishra J, Verma RK, Alpini G, Meng F, Kumar N. Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome. J Biol Chem 2015;290:29301-12. [PMID: 26451047 DOI: 10.1074/jbc.M115.670331] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
11 Solga SF. Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward. World J Gastroenterol 2014;20:9017-25. [PMID: 25083075 DOI: 10.3748/wjg.v20.i27.9017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Shu X, Wang M, Xu H, Liu Y, Huang J, Yao Z, Zhang L. Extracts of Salvia-Nelumbinis Naturalis Ameliorate Nonalcoholic Steatohepatitis via Inhibiting Gut-Derived Endotoxin Mediated TLR4/NF-κB Activation. Evid Based Complement Alternat Med 2017;2017:9208314. [PMID: 28831287 DOI: 10.1155/2017/9208314] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Muscogiuri G, Cantone E, Cassarano S, Tuccinardi D, Barrea L, Savastano S, Colao A; on behalf of the Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group. Gut microbiota: a new path to treat obesity. Int J Obes Suppl 2019;9:10-9. [PMID: 31391921 DOI: 10.1038/s41367-019-0011-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 54] [Article Influence: 36.0] [Reference Citation Analysis]
14 Raza S, Rajak S, Upadhyay A, Tewari A, Anthony Sinha R. Current treatment paradigms and emerging therapies for NAFLD/NASH. Front Biosci (Landmark Ed) 2021;26:206-37. [PMID: 33049668 DOI: 10.2741/4892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
15 Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang ZZ, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ. Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. J Clin Invest. 2015;125:386-402. [PMID: 25500885 DOI: 10.1172/jci76738] [Cited by in Crossref: 330] [Cited by in F6Publishing: 204] [Article Influence: 47.1] [Reference Citation Analysis]
16 Duarte SMB, Stefano JT, Oliveira CP. Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Ann Hepatol 2019;18:416-21. [PMID: 31036494 DOI: 10.1016/j.aohep.2019.04.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
17 Famouri F, Shariat Z, Hashemipour M, Keikha M, Kelishadi R. Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. J Pediatr Gastroenterol Nutr 2017;64:413-7. [PMID: 28230607 DOI: 10.1097/MPG.0000000000001422] [Cited by in Crossref: 89] [Cited by in F6Publishing: 42] [Article Influence: 29.7] [Reference Citation Analysis]
18 Xu Q, Li Y, Shang YF, Wang HL, Yao MX. miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. World J Gastroenterol. 2015;21:511-516. [PMID: 25593466 DOI: 10.3748/wjg.v21.i2.511] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
19 Kim EJ, Kim HJ. Nonalcoholic fatty liver disease in obese and nonobese pediatric patients. Korean J Pediatr 2019;62:30-5. [PMID: 30304905 DOI: 10.3345/kjp.2018.06786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Gonzalez FJ, Jiang C, Patterson AD. An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease. Gastroenterology. 2016;151:845-859. [PMID: 27639801 DOI: 10.1053/j.gastro.2016.08.057] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 25.0] [Reference Citation Analysis]
21 Chakraborti CK. New-found link between microbiota and obesity. World J Gastrointest Pathophysiol 2015;6:110-9. [PMID: 26600968 DOI: 10.4291/wjgp.v6.i4.110] [Cited by in CrossRef: 156] [Cited by in F6Publishing: 137] [Article Influence: 26.0] [Reference Citation Analysis]
22 García-alonso FJ, González-barrio R, Martín-pozuelo G, Hidalgo N, Navarro-gonzález I, Masuero D, Soini E, Vrhovsek U, Periago MJ. A study of the prebiotic-like effects of tomato juice consumption in rats with diet-induced non-alcoholic fatty liver disease (NAFLD). Food Funct 2017;8:3542-52. [DOI: 10.1039/c7fo00393e] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
23 Nobili V, Cucchiara S. The Use of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: Teachable Moment or Missed Opportunity? Journal of Pediatric Gastroenterology & Nutrition 2017;64:336-7. [DOI: 10.1097/mpg.0000000000001431] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Vítek L, Haluzík M. The role of bile acids in metabolic regulation. J Endocrinol. 2016;228:R85-R96. [PMID: 26733603 DOI: 10.1530/joe-15-0469] [Cited by in Crossref: 68] [Cited by in F6Publishing: 33] [Article Influence: 13.6] [Reference Citation Analysis]
25 Lau AS, Mitsuyama E, Odamaki T, Xiao J, Liong M. El Niño Altered Gut Microbiota of Children: A New Insight on Weather–Gut Interactions and Protective Effects of Probiotic. Journal of Medicinal Food 2019;22:230-40. [DOI: 10.1089/jmf.2018.4276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Drosos I, Tavridou A, Kolios G. New Aspects on the Metabolic role of Intestinal Microbiota in the Development of Atherosclerosis. Metabolism 2015;64:476-81. [DOI: 10.1016/j.metabol.2015.01.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
27 Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017;71:182-97. [DOI: 10.1016/j.metabol.2017.03.013] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 16.8] [Reference Citation Analysis]
28 Lian C, Zhai Z, Li Z, Wang L. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chemico-Biological Interactions 2020;330:109199. [DOI: 10.1016/j.cbi.2020.109199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]